China state-affiliated media AstraZeneca Plc and Shenzhen Kangtai Biological Products entered a deal to produce the UK drugmaker’s promising COVID-19 vaccine. Shenzhen Kangtai agreed to build capacity to make at least 100 mln doses of the shot by year-end, and 200 mln by end of 2021, Astra said.
【 以下文字转载自 Military 讨论区 】
发信人: swordzz2 (swordzz2), 信区: Military
标 题: 土共获英国阿斯利康授权生产3亿支COVID19疫苗供大陆市场
发信站: BBS 未名空间站 (Fri Aug 7 22:58:35 2020, 美东)
中國獲得英國阿斯利康授權生產3億支COVID19疫苗供中國市場，由深圳康泰生產。
中共黨員是否用國產疫苗？普通民众能否用上外国疫苗？？？
China Economy
@CE_ChinaEconomy
China state-affiliated media
AstraZeneca Plc and Shenzhen Kangtai Biological Products entered a deal to
produce the UK drugmaker’s promising COVID-19 vaccine. Shenzhen Kangtai
agreed to build capacity to make at least 100 mln doses of the shot by year-end, and 200 mln by end of 2021, Astra said.